Search Results
Search for other papers by Pedro Weslley Rosario in
Google Scholar
PubMed
Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed
Search for other papers by Maria Regina Calsolari in
Google Scholar
PubMed
Introduction Ultrasonography (US) is a widely available, noninvasive, and sensitive technique for the detection of locoregional disease in patients operated on for papillary thyroid carcinoma (PTC). After ablation or adjuvant therapy with
Search for other papers by Daniela Cavaco in
Google Scholar
PubMed
Search for other papers by Ana Filipa Martins in
Google Scholar
PubMed
Search for other papers by Rafael Cabrera in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the most common thyroid cancer, accounting for more than 85% of the thyroid malignant lesions ( 1 ). An increase of its prevalence is recognized worldwide, mainly due to overdiagnosis of
Search for other papers by Marco Capezzone in
Google Scholar
PubMed
Search for other papers by Noemi Fralassi in
Google Scholar
PubMed
Search for other papers by Chiara Secchi in
Google Scholar
PubMed
Search for other papers by Silvia Cantara in
Google Scholar
PubMed
Search for other papers by Lucia Brilli in
Google Scholar
PubMed
Search for other papers by Tania Pilli in
Google Scholar
PubMed
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Raffaella Forleo in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Gabriele Cevenini in
Google Scholar
PubMed
Search for other papers by Alessandra Cartocci in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
. 10.1530/ERC-16-0067 27807061 1351-0088 7 Pinto AE , Silva GL , Henrique R , Menezes FD , Teixeira MR , Leite V , et al. Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar
Search for other papers by Elen Dias Accordi in
Google Scholar
PubMed
Search for other papers by Paraskevi Xekouki in
Google Scholar
PubMed
Search for other papers by Bruna Azevedo in
Google Scholar
PubMed
Search for other papers by Rodrigo Bertollo de Alexandre in
Google Scholar
PubMed
Álvaro Center for Analysis and Clinical Research - Diagnósticos da América (DASA), Cascavel, Brazil
Search for other papers by Carla Frasson in
Google Scholar
PubMed
Search for other papers by Siliane Marie Gantzel in
Google Scholar
PubMed
Search for other papers by Georgios Z. Papadakis in
Google Scholar
PubMed
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Constantine A. Stratakis in
Google Scholar
PubMed
Search for other papers by Vanessa Santos Sotomaior in
Google Scholar
PubMed
Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics (PDEGEN) and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
Search for other papers by Fabio R. Faucz in
Google Scholar
PubMed
collectively classified as well-differentiated thyroid cancers and account for around 95% of thyroid malignancies. Although the majority of papillary and follicular thyroid carcinomas are sporadic, familial tumors may account for 5-10% of thyroid carcinoma
Search for other papers by Dillwyn Williams in
Google Scholar
PubMed
incidence at age 30-39 is about the same as the incidence in those over 80. The great majority of thyroid carcinomas are papillary in type. This analysis is primarily concerned with papillary carcinoma, although the main conclusions on age of origin will
Search for other papers by Francesca Carlomagno in
Google Scholar
PubMed
of the RET gene have been identified in two different types of thyroid neoplasia: medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma. RET Mutations in MTC: A New Target for Cancer Treatment MTC arises from neural crest
Search for other papers by Nooshin Zargari in
Google Scholar
PubMed
Search for other papers by Maral Mokhtari in
Google Scholar
PubMed
carcinoma (FC), and follicular variant of papillary thyroid carcinoma (FVPTC). The standard diagnosis of thyroid tumors is based on hematoxylin-eosin (HE)-stained slides, but sometimes the diagnosis of thyroid lesions, especially follicular patterned thyroid
Search for other papers by Anne-Sophie Bertrand in
Google Scholar
PubMed
Search for other papers by Antoine Iannessi in
Google Scholar
PubMed
Search for other papers by Isabelle Peyrottes in
Google Scholar
PubMed
Search for other papers by Alexis Lacout in
Google Scholar
PubMed
Search for other papers by Antoine Thyss in
Google Scholar
PubMed
Search for other papers by Pierre-Yves Marcy in
Google Scholar
PubMed
case of tumor-to-tumor metastasis from a well-differentiated papillary thyroid carcinoma (PTC) into a benign uterine leiomyoma. Case Presentation We present the case of a 53-year-old female patient with a slow-growing latero-uterine mass on
Search for other papers by Andrea Palermo in
Google Scholar
PubMed
Search for other papers by Andrea Napolitano in
Google Scholar
PubMed
Search for other papers by Daria Maggi in
Google Scholar
PubMed
Search for other papers by Anda Mihaela Naciu in
Google Scholar
PubMed
Search for other papers by Gaia Tabacco in
Google Scholar
PubMed
Search for other papers by Silvia Manfrini in
Google Scholar
PubMed
Search for other papers by Anna Crescenzi in
Google Scholar
PubMed
Search for other papers by Chiara Taffon in
Google Scholar
PubMed
Search for other papers by Francesco Pantano in
Google Scholar
PubMed
Search for other papers by Bruno Vincenzi in
Google Scholar
PubMed
Search for other papers by Guiseppe Tonini in
Google Scholar
PubMed
Search for other papers by Daniele Santini in
Google Scholar
PubMed
papillary thyroid carcinoma. The presence of histiocyte aggregates on the site where the prior nodule had been observed supports the hypothesis of an immune-mediated tumor regression. Introduction Immune checkpoint inhibitors have been
Search for other papers by Daniela Dias in
Google Scholar
PubMed
Search for other papers by Inês Damásio in
Google Scholar
PubMed
Search for other papers by Pedro Marques in
Google Scholar
PubMed
Search for other papers by Helder Simões in
Google Scholar
PubMed
Search for other papers by Ricardo Rodrigues in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Nova Medical School: Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
response. Discussion Follicular thyroid carcinoma (FTC) is a rare cancer, corresponding to less than 10% of all differentiated thyroid cancer (DTC). Compared to classic papillary thyroid carcinoma (PTC), FTC displays a different clinical behavior